Licitra LF - Search Results

1

Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design.

Bourhis J, Burtness B, Licitra LF, Nutting C, Schoenfeld JD, Omar M, Bouisset F, Nauwelaerts H, Urfer Y, Zanna C, Cohen EE. Bourhis J, et al. Among authors: licitra lf. Future Oncol. 2022 May;18(14):1669-1678. doi: 10.2217/fon-2021-1634. Epub 2022 Feb 17. Future Oncol. 2022. PMID: 35172587 Free article.

2

Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R, Cantù G. Licitra L, et al. J Clin Oncol. 2003 Jan 15;21(2):327-33. doi: 10.1200/JCO.2003.06.146. J Clin Oncol. 2003. PMID: 12525526 Clinical Trial.

3

Head and neck tumors other than squamous cell carcinoma.

Licitra L, Locati LD, Bossi P, Cantù G. Licitra L, et al. Curr Opin Oncol. 2004 May;16(3):236-41. doi: 10.1097/00001622-200405000-00008. Curr Opin Oncol. 2004. PMID: 15069319 Review.

4

A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new?

Licitra L, Bossi P, Locati LD. Licitra L, et al. Curr Opin Oncol. 2006 May;18(3):253-7. doi: 10.1097/01.cco.0000219254.53091.35. Curr Opin Oncol. 2006. PMID: 16552237 Review.

5

Biological agents in head and neck cancer.

Bossi P, Locati LD, Licitra L. Bossi P, et al. Expert Rev Anticancer Ther. 2007 Nov;7(11):1643-50. doi: 10.1586/14737140.7.11.1643. Expert Rev Anticancer Ther. 2007. PMID: 18020930 Review.

6

Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].

Stewart JS, Cohen EE, Licitra L, Van Herpen CM, Khorprasert C, Soulieres D, Vodvarka P, Rischin D, Garin AM, Hirsch FR, Varella-Garcia M, Ghiorghiu S, Hargreaves L, Armour A, Speake G, Swaisland A, Vokes EE. Stewart JS, et al. J Clin Oncol. 2009 Apr 10;27(11):1864-71. doi: 10.1200/JCO.2008.17.0530. Epub 2009 Mar 16. J Clin Oncol. 2009. PMID: 19289630 Clinical Trial.

7

TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.

Perrone F, Bossi P, Cortelazzi B, Locati L, Quattrone P, Pierotti MA, Pilotti S, Licitra L. Perrone F, et al. J Clin Oncol. 2010 Feb 10;28(5):761-6. doi: 10.1200/JCO.2009.22.4170. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048189 Clinical Trial.

8

Head and neck cancer.

Psyrri A, Burtness B, Harari PM, Vermorken JB, Licitra L, Sasaki CT. Psyrri A, et al. J Oncol. 2009;2009:358098. doi: 10.1155/2009/358098. Epub 2010 Feb 4. J Oncol. 2009. PMID: 20169126 Free PMC article. No abstract available.

9

Targeted therapy in head and neck cancer.

Licitra L, Bergamini C, Mirabile A, Granata R. Licitra L, et al. Curr Opin Otolaryngol Head Neck Surg. 2011 Apr;19(2):132-7. doi: 10.1097/MOO.0b013e328344b668. Curr Opin Otolaryngol Head Neck Surg. 2011. PMID: 21372717 Review.

10

Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer.

Bossi P, Kornek G, Lanzetta G, Rozzi A, Füreder T, Locati L, Licitra L. Bossi P, et al. Head Neck. 2013 Oct;35(10):1471-4. doi: 10.1002/hed.23170. Epub 2012 Oct 6. Head Neck. 2013. PMID: 23042567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page